Skip to main navigation Skip to search Skip to main content

RPL5 on 1p22.1 is recurrently deleted in multiple myeloma and its expression is linked to bortezomib response

  • I. J.F. Hofman
  • , M. Van Duin
  • , E. De Bruyne
  • , L. Fancello
  • , G. Mulligan
  • , E. Geerdens
  • , E. Garelli
  • , C. Mancini
  • , H. Lemmens
  • , M. Delforge
  • , P. Vandenberghe
  • , I. Wlodarska
  • , A. Aspesi
  • , L. Michaux
  • , K. Vanderkerken
  • , P. Sonneveld
  • , K. De Keersmaecker

Research output: Contribution to journalArticlepeer-review

Abstract

Chromosomal

Original languageEnglish
Pages (from-to)1706-1714
Number of pages9
JournalLeukemia
Volume31
Issue number8
DOIs
Publication statusPublished - 1 Aug 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'RPL5 on 1p22.1 is recurrently deleted in multiple myeloma and its expression is linked to bortezomib response'. Together they form a unique fingerprint.

Cite this